达安基因(002030) - 2014年7月14日调研活动附件

Group 1: Company Representatives - The company’s securities affairs representative, Zeng Yuting, and board secretary, Zhang Bin, were present with researchers from various investment firms [2][3] Group 2: Institutional Collaborations - Collaborating institutions include Franklin Templeton Securities Investment Trust Co., Ltd., Guosen Securities Co., Ltd., Hanlun Investment Consulting (Shanghai) Co., Ltd., and Future Asset Yicai Investment Consulting (Shanghai) Co., Ltd. [2][3]